This IEEE Pulse Industry Corner interview features Dr. Anders Sideris, CEO of Somnair, discussing his journey from practicing ENT surgeon to medical device innovator in the sleep medicine space. Dr. Sideris, an Australian-trained physician who completed his medical education in 2015, identified significant gaps in sleep apnea treatment during his clinical practice in Sydney. This clinical insight and engineering training culminated in the founding of Somnair, leveraging the Johns Hopkins ecosystem to develop new technologies addressing the unmet needs of sleep apnea patients who remain untreated by current therapeutic options.

Flipping the Script: How New Drugs are Disrupting Sleep Apnea Care examines the impact of emerging pharmaceutical interventions on treating obstructive sleep apnea, particularly in relation to weight loss drugs and other options.

Sleep is fundamental to health and productivity, with insufficient rest linked to rising economic losses. Advances in wearables and non-contact sensors have transformed sleep monitoring from hospital-based polysomnography to everyday tracking via watches, rings, and beds. While consumer devices capture broad patterns, dedicated and FDA-cleared systems now approach clinical accuracy for disorders like sleep apnea. Embedded electronics and AI are driving the emergence of digital biomarkers, enabling personalized insights and long-term monitoring. This article reviews the evolution of sleep sensors, their convergence with clinical practice, and their growing role in preventive health.